C-Rad AB (CRADb)

Currency in SEK
36.20
+0.60(+1.69%)
Closed·
CRADb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.6036.80
52 wk Range
24.6039.40
Key Statistics
Prev. Close
35.6
Open
35.6
Day's Range
35.6-36.8
52 wk Range
24.6-39.4
Volume
5.66K
Average Volume (3m)
20.72K
1-Year Change
5.848%
Book Value / Share
10.85
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CRADb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
45.00
Upside
+24.31%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 45.00
(+24.31% Upside)

Earnings

Latest Release
17-07-2026
EPS / Forecast
0.72 / 0.31
Revenue / Forecast
121.7M / 112.7M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.49%
Dividend Yield
0.28%
Industry Median 1.80%
Annualised payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

CRADb Income Statement

Compare CRADb to Peers and Sector

Metrics to compare
CRADb
Peers
Sector
Relationship
P/E Ratio
24.9x−8.1x−0.4x
PEG Ratio
0.2629.520.00
Price/Book
3.4x2.5x2.6x
Price / LTM Sales
2.8x3.7x3.1x
Upside (Analyst Target)
22.3%0.0%48.5%
Fair Value Upside
Unlock14.0%5.8%Unlock

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating; and Sentinel 4DCT, a laser-based optical surface scanning system. It also provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; and visual coaching solutions used for prospective and retrospective radiotherapy. In addition, the company offers cAutoVerify, an automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking. Further, it provides HIT1, HIT3, and HIT5 patient positioning laser, as well as laser positioning products and solutions. Additionally, the company offers support and training services; and service contracts. C-Rad AB (publ) was incorporated in 2004 and is headquartered in Uppsala, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.13M3.34%40.16M
Other Institutional Investors
15.59M46.17%555.06M
Public Companies & Retail Investors
17.05M50.49%606.88M
Total
33.77M100.00%1.2B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Svea Bank AB (publ)11.92%40,24,9691,43,289
Linc AB11.23%37,92,4201,35,010

FAQ

What Is the C-Rad (CRADb) Share Price Today?

The C-Rad share price today is 36.20.

What is the current C-Rad (CRADb) share price and day range?

As of 10-08-2026, the C-Rad share price is 36.20, with a previous close of 35.60. The share price has ranged from 35.60 to 36.80 today, while the 52-week range spans from 24.60 to 39.40.

What Is the C-Rad Market Cap?

As of today, C-Rad market cap is 1.20B.

Does C-Rad Pay Dividends? What's The Current Dividend Yield?

The C-Rad dividend yield is 0.28%.

What Is the C-Rad (CRADb) Share Price Target?

The average 12-month share price target for C-Rad is 45.00, with a high estimate of 45 and a low estimate of 45. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +24.31% Upside potential.

What Is C-Rad's Earnings Per Share (TTM)?

The C-Rad EPS (TTM) is 1.49.

When Is the Next C-Rad Earnings Date?

C-Rad will release its next earnings report on 22-10-2026.

From a Technical Analysis Perspective, Is CRADb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does C-Rad Trade On?

C-Rad is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for C-Rad?

The stock symbol for C-Rad is "CRADb."

How Many Times Has C-Rad Stock Split?

C-Rad has split 3 times.

How Many Employees Does C-Rad Have?

C-Rad has 98 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.